Clinical Trial Update: Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial) [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 trial (EXAMI) evaluating additional treatment with exenatide in patients after a first acute myocardial infarction treated with P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Patients With a First Acute Myocardial Infarction to be Treated With Primary Percutaneous Coronary Intervention (PCI). | Phase 3 | Status: UNKNOWN